Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleToxicology

Pharmacological Characterization of the Edema Caused by Vitalius dubius (Theraphosidae, Mygalomorphae) Spider Venom in Rats

Thomaz A. A. Rocha-e-Silva, Alessandra Linardi, Edson Antunes and Stephen Hyslop
Journal of Pharmacology and Experimental Therapeutics January 2016, 356 (1) 13-19; DOI: https://doi.org/10.1124/jpet.115.226787
Thomaz A. A. Rocha-e-Silva
Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Cidade Universitária Zeferino Vaz, Campinas, São Paulo, Brazil (T.A.A.R.S., E.A., S.H.); and Departamento de Ciências Fisiológicas, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil (T.A.A.R.S., A.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Linardi
Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Cidade Universitária Zeferino Vaz, Campinas, São Paulo, Brazil (T.A.A.R.S., E.A., S.H.); and Departamento de Ciências Fisiológicas, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil (T.A.A.R.S., A.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edson Antunes
Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Cidade Universitária Zeferino Vaz, Campinas, São Paulo, Brazil (T.A.A.R.S., E.A., S.H.); and Departamento de Ciências Fisiológicas, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil (T.A.A.R.S., A.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Hyslop
Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Cidade Universitária Zeferino Vaz, Campinas, São Paulo, Brazil (T.A.A.R.S., E.A., S.H.); and Departamento de Ciências Fisiológicas, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil (T.A.A.R.S., A.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Rat dorsal skin plasma extravasation caused by V. dubius venom. The rats were anesthetized with thiopental, the dorsal skin was shaved, and the animals received an i.v. injection of 125I-human serum albumin (2.5μCi/rat) with Evan's blue dye (25mg/kg). This was followed by the intradermal injection of vehicle (Tyrode) solution or venom (1–100 μg/site) in a fixed volume (100μl) using a random order and balanced site pattern. Thirty minutes later, the rats were euthanized, the dorsal skin was removed, and the injected sites were punched out and counted in a gamma counter to determine the extent of plasma extravasation (based on the accumulation of radiolabeled albumin). Plasma extravasation was expressed as the volume (μl) of plasma accumulated at each skin site. The columns represent the mean ± S.E.M. (n = 6). *P < 0.05 compared with vehicle (Tyrode) solution (column with 0 µg venom/site).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    The role of histamine, serotonin, bradykinin, and COX products in V. dubius (Vd) venom-induced plasma extravasation. The rats were prepared and treated as described in the legend for Fig. 1, except that prior to venom injection they received mepyramine (histamine H1 receptor antagonist; 6 mg/kg, i.p., 15 minutes before), cyproheptadine (dual serotonin 5-hydroxytryptamine1/2 and histamine H1 receptor antagonist; 2 mg/kg, i.p., 30 minutes before), JE 049 (B2 receptor antagonist; 0.6 mg/kg, i.v., 15 minutes before), or indomethacin (nonselective COX inhibitor; 10 mg/kg, i.p., 1 hour before). Subsequently, vehicle (Tyrode) solution, the respective positive control, and venom (10 µg/site) were injected intradermally in a fixed volume (100μl). Thirty minutes later, the rats were euthanized and processed, as described in Fig. 1. Plasma extravasation was expressed as the volume (μl) of plasma accumulated at each skin site. Histamine (His, 30 nmol/site), compound 48/80 (C48/80, 1 μg/site), and bradykinin (BK, 0,1 nmol/site?) were used as positive controls. The columns represent the mean ± S.E.M. (n = 6). *P < 0.05 compared with vehicle (Tyrode) solution and #P < 0.05 compared with the corresponding response to venom alone.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Role of nitric oxide and neurokinins in V. dubius (Vd) venom-induced plasma extravasation. The rats were prepared and treated as described in the legend for Fig. 1, except that prior to venom injection they received (Upper panel) L-NAME (nitric oxide synthase inhibitor; 100 nmol/site) and (Lower panel) SR140333 (neurokinin NK1 receptor antagonist; 1 nmol/site) or SR48968 (neurokinin NK2 receptor antagonist; 0.3 µmol/kg, i.v.) that were coadministered with venom (10 µg/site) in a fixed volume (100μl). Thirty minutes later, the rats were euthanized and processed as described in Fig. 1. Plasma extravasation was expressed as the volume (μl) of plasma accumulated at each skin site. The columns represent the mean ± S.E.M. (n = 6). *P < 0.05 compared with vehicle (Tyrode) solution and #P < 0.05 compared with the corresponding response to venom alone.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Attenuation of V. dubius venom-induced rat hind paw edema by ketoprofen (cyclooxygenase inhibitor; 20 mg/kg, i.p.) administered 15 minutes after venom. Rats were lightly anesthetized with isoflurane for venom injection in the subplantar region of the right hind paw. The paw volume was measured immediately before the injection of venom (20 μg/paw) or 0.9% NaCl (vehicle control) and at various intervals thereafter using a plethysmometer. The volume injected into the paws was always 100 μl. The increase in paw volume (ml) was calculated as the difference between the basal and final volumes. The points represent the mean ± S.E.M. (n = 6). All time points in the venom + saline and venom + ketoprofen groups were significantly different from the corresponding controls. *P < 0.05 compared with the corresponding times in the venom + saline group.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Neutralization of V. dubius (Vd, 10 μg/site), P. nigriventer (Pn, 5 μg/site), and T. serrulatus (Ts, 5 μg/site) venom-induced plasma extravasation by IgG purified from antiarachnid antivenom. The venoms were incubated with IgG purified from antiarachnid antivenom (0.3 mg/ml for V. dubius and 0.1 mg/ml for P. nigriventer and T. serrulatus) for 1 hour at 37°C prior to testing in rat dorsal skin. The venom:IgG ratios used for these neutralization assays were 1:2 for P. nigriventer and T. serrulatus and 1:3 for V. dubius. Plasma extravasation was assessed by injecting venom and venom + antivenom IgG mixtures intradermally in the dorsal skin of anesthetized rats. Thirty minutes later, the rats were euthanized and processed, as described in Fig. 1. Plasma extravasation was expressed as the volume (μl) of plasma accumulated at each skin site. The columns represent the mean ± S.E.M. (n = 6). *P < 0.05 compared with vehicle (Tyrode) solution and #P < 0.05 compared with the corresponding response to venom alone.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 356 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 356, Issue 1
1 Jan 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological Characterization of the Edema Caused by Vitalius dubius (Theraphosidae, Mygalomorphae) Spider Venom in Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleToxicology

Vitalius dubius Venom-Induced Edema

Thomaz A. A. Rocha-e-Silva, Alessandra Linardi, Edson Antunes and Stephen Hyslop
Journal of Pharmacology and Experimental Therapeutics January 1, 2016, 356 (1) 13-19; DOI: https://doi.org/10.1124/jpet.115.226787

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleToxicology

Vitalius dubius Venom-Induced Edema

Thomaz A. A. Rocha-e-Silva, Alessandra Linardi, Edson Antunes and Stephen Hyslop
Journal of Pharmacology and Experimental Therapeutics January 1, 2016, 356 (1) 13-19; DOI: https://doi.org/10.1124/jpet.115.226787
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Tolerability profile of a GalNAc3-conjugated ASO in Monkeys
  • Preclinical Safety of Lung Instillation of Thyroid Hormone
  • Nefazodone Inhibits Anaerobic Glycolysis
Show more Toxicology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics